- Midyorkshire NHS Trust
- United Kingdom
We and selected partners, use cookies or similar technologies as specified in the cookie policy and privacy policy.
You can consent to the use of such technologies by closing this notice.
Customise your preferences for any tracking technology
The following allows you to customize your consent preferences for any tracking technology used to help us achieve the features and activities described below. To learn more about how these trackers help us and how they work, refer to the cookie policy. You may review and change your preferences at any time.
These trackers are used for activities that are strictly necessary to operate or deliver the service you requested from us and, therefore, do not require you to consent.
These trackers help us to deliver personalized marketing content and to operate, serve and track ads.
These trackers help us to deliver personalized marketing content to you based on your behaviour and to operate, serve and track social advertising.
These trackers help us to measure traffic and analyze your behaviour with the goal of improving our service.
These trackers help us to provide a personalized user experience by improving the quality of your preference management options, and by enabling the interaction with external networks and platforms.
Recent Comments
Hi,
Sending a second request to ask if you could provide us with for final scores for pelvic pain, dysmenorrhoea and dyspareunia in order to enable us to perform a meta-analysis with other papers to identify the effectiveness of GnRH anatagonists in the management of endometriotic pain.
Many thanks
Hi, I am sending a second request regarding obtaining further information on the final scores on dysmenorrhoea, non menstrual pelvic pain, dyschezia, difficutly in doing daily activity and dyspareunia on the above article in order for us to perform a meta-analysis with other papers on the effectiveness of GnRH antagonists on endometriosis. Many thanks
I am part of a team currently working on a cochrane review on the benefits of GnRH antagonists as a treatment for endometriotic pain. This trial has been selected for the meta-analysis. Following discussions with our statistician we would like to ask the authors whether they could provide us with final scores (as appose to the change from baseline published in the paper) for pelvic pain, dysmenorrhoea and and dyspareunia. This would help us enormously with the data analysis in the final meta-analysis. Thank you
I am part of a team currently working on a cochrane review on the benefits of GnRH antagonists on the treatment for endometriotic pain. Your study has been selected for the meta-analysis. Following discussions with our statistician we would like to ask the authors whether they could provide us with final scores (as appose to the change in score or difference from placebo published in the paper) for dysmenorrhoea, non menstrual pelvic pain, dyschezia, difficulty in doing daily activity and dyspareunia. This would help us enormously with the data analysis in the final meta-analysis.
Many thanks